Surmodics
SRDX
SRDX was delisted on the 18th of November, 2025.
140 hedge funds and large institutions have $532M invested in Surmodics in 2020 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 42 increasing their positions, 53 reducing their positions, and 13 closing their positions.
12% more capital invested
Capital invested by funds: $475M → $532M (+$57.3M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.01% less ownership
Funds ownership: 89.41% → 89.39% (-0.01%)
1% less funds holding
Funds holding: 141 → 140 (-1)
8% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 13
21% less repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 53
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $366K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$2.15M |
| 2 |
EP
Eversept Partners
New York
|
+$1.63M |
| 3 |
Morgan Stanley
New York
|
+$1.22M |
| 4 |
WCM
Wedge Capital Management
Charlotte,
North Carolina
|
+$1.06M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$857K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MAM
Martingale Asset Management
Boston,
Massachusetts
|
-$1.14M |
| 2 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$1.11M |
| 3 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$1.06M |
| 4 |
State Street
Boston,
Massachusetts
|
-$847K |
| 5 |
MCM
Matarin Capital Management
New York
|
-$786K |
SRDX Hedge Fund Activity: Q4 2020 in Review
140 of the 5,676 institutional investors tracked by Wall St. Rank reported a position in Surmodics (SRDX) for Q4 2020, worth a combined $532M — up 12% from $475M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of SRDX and 12 opened new positions — a net loss of 1 holder — while 53 trimmed existing stakes and 42 added.
The largest buyer was BlackRock, adding an estimated $2.15M. The largest seller was Martingale Asset Management, cutting an estimated $1.14M.
- 140 institutional investors held Surmodics (SRDX) as of Q4 2020, down from 141 in Q3 2020.
- Funds reported $532M of Surmodics stock for Q4 2020, up 12% quarter-over-quarter.
- 12 funds opened new Surmodics positions in Q4 2020 and 13 closed out, a net change of -1 holder.
- The largest Surmodics buyer in Q4 2020 was BlackRock, an estimated $2.15M added.
- The largest Surmodics seller in Q4 2020 was Martingale Asset Management, an estimated $1.14M sold.
Based on aggregated 13F filings for Q4 2020.